Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Japan
Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Angiology. 2015 Feb;66(2):187-94. doi: 10.1177/0003319714523113. Epub 2014 Feb 26.
Although limb salvage rate has improved in critical limb ischemia (CLI), an improvement in CLI prognosis has been scarcely reported. Multidisciplinary therapy (MT) including revascularization, wound bed preparation, treatment of comorbidity, and education of patients with CLI may improve prognosis. The aim of this study was to investigate the effectiveness of MT in prognostic improvement. We retrospectively analyzed 72 patients with CLI and assessed whether MT improved prognosis. The incidence of amputation-free survival (freedom from major amputation [MA] and death) was significantly different between the MT and conventional groups at 2 years (0% vs 33%; P = .024). After multivariate analysis, transfusion (hazard ratio [HR] 5.778; 95% confidence interval [CI], 2.372-14.073; P < .001), multivessel coronary disease (HR 3.353; 95% CI, 1.309-8.590; P = .012), and C-reactive protein >5 mg/dL (HR 3.958; 95% CI, 1.359-11.531; P = .012) were independent predictors for MA or death. We concluded that MT was effective in improved mortality and limb salvage rate.
尽管在严重肢体缺血(CLI)中保肢率有所提高,但 CLI 预后的改善却鲜有报道。多学科治疗(MT)包括血运重建、创面准备、合并症治疗和 CLI 患者教育,可能改善预后。本研究旨在探讨 MT 在预后改善方面的效果。我们回顾性分析了 72 例 CLI 患者,并评估了 MT 是否改善了预后。在 2 年时,MT 组和常规组的无截肢生存率(免于主要截肢[MA]和死亡)差异有统计学意义(0% vs 33%;P =.024)。多因素分析显示,输血(危险比[HR] 5.778;95%置信区间[CI],2.372-14.073;P <.001)、多支冠状动脉疾病(HR 3.353;95% CI,1.309-8.590;P =.012)和 C 反应蛋白>5mg/dL(HR 3.958;95% CI,1.359-11.531;P =.012)是 MA 或死亡的独立预测因素。我们得出结论,MT 可有效改善死亡率和保肢率。